Literature DB >> 12297114

Sample handling and stability of hepatocyte growth factor in blood samples.

Fariba Nayeri1, Lars Brudin, Ingela Nilsson, Pia Forsberg.   

Abstract

As regards clinical studies performed on hepatocyte growth factor (HGF) during recent years, we have aimed in the present study to investigate the eventual differences in sample handling of this cytokine that might influence the results of serum concentrations. Venous blood from patients with current infectious diseases and controls was used in different sub-studies. Compared with samples separated within one hour, no significant changes in serum HGF levels were observed when whole blood stayed 4, or 24h at 6 degrees C before or 6h in room temperature after separation but HGF levels were significantly higher (P<0.01) when whole blood was kept at room temperature 4 and 24h before separation. Serum HGF was stable up to 20 freeze-thaw cycles. The serum concentrations of HGF were significantly higher than levels in the plasma (19%; P<0.05). A significant increase in serum HGF levels (12%, P<0.05) was observed after shaking the whole blood sample to a visible haemolysis, although the HGF concentration in blood cells was around half of that in serum. HGF tolerated storage at -70 degrees C for at least 4 months. We conclude that standardized methods in sample handling are important in the study of HGF concentrations in blood samples. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297114     DOI: 10.1006/cyto.2002.1050

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Methodical and pre-analytical characteristics of a multiplex cancer biomarker immunoassay.

Authors:  Natalie Hermann; Katja Dreßen; Frank A Schildberg; Christopher Jakobs; Stefan Holdenrieder
Journal:  World J Methodol       Date:  2014-12-26

2.  Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

Authors:  K Brookes; J Cummings; A Backen; A Greystoke; T Ward; G C Jayson; C Dive
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

3.  Temporal reliability of cytokines and growth factors in EDTA plasma.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Annika Idahl; Göran Hallmans; Karen L Koenig; Adele M Marrangoni; Brian M Nolen; Nina Ohlson; Anne Zeleniuch-Jacquotte; Eva Lundin
Journal:  BMC Res Notes       Date:  2010-11-13

4.  Hepatocyte growth factor (HGF) in fecal samples: rapid detection by surface plasmon resonance.

Authors:  Fariba Nayeri; Daniel Aili; Tayeb Nayeri; Junyang Xu; Sven Almer; Ingemar Lundström; Britt Akerlind; Bo Liedberg
Journal:  BMC Gastroenterol       Date:  2005-04-12       Impact factor: 3.067

5.  Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis.

Authors:  Amir Ramezani; Katarina Nägga; Oskar Hansson; Johanna Lönn; Johanna Sjöwall; Fateme Katoozian; Sepahdar Mansouri; Fariba Nayeri
Journal:  Fluids Barriers CNS       Date:  2015-09-25

6.  Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor.

Authors:  Fariba Nayeri; Tayeb Nayeri; Daniel Aili; Lars Brudin; Bo Liedberg
Journal:  Growth Factors       Date:  2008-06       Impact factor: 2.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.